She was diagnosed and enrolled during December 2011 and I don't remember being informed about the MGMT methylation status. I only learned the significance when i started researching more about GBM treatment during early 2019 after her GBM came back. I believer her physician at New York Presbyterian told us they did a genetic analysis of the 2nd tumor and thought Avastin was her best option.
Market Data 
Markets 
AI
